The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis

por Shi, Xin, Zheng, Yanhua, Xu, Li, Cao, Chun, Dong, Baoxia, Chen, Xiequn
Publicado 2019

Chidamide epigenetically represses autophagy and exerts cooperative antimyeloma activity with bortezomib

por Xu, Li, Feng, Juan, Tang, Hailong, Dong, Ying, Shu, Mimi, Chen, Xiequn
Publicado 2020

Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia

por Bi, Lei, Jia, Shuangshuang, Hu, Wuyue, Su, Xiaoli, Chen, Xiequn, Tang, Hailong
Publicado 2022

CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1

por DONG, BAOXIA, SOMANI, ALLY-KHAN, LOVE, PAUL E., ZHENG, XUAN, CHEN, XIEQUN, ZHANG, JINYI
Publicado 2016

Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA stability

por Gao, Guangxun, Chen, Liang, Li, Jingxia, Zhang, Dongyun, Fang, Yong, Huang, Haishan, Chen, Xiequn, Huang, Chuanshu
Publicado 2014

Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple M...

por Zheng, Yanhua, Shen, Hongyuan, Xu, Li, Feng, Juan, Tang, Hailong, Zhang, Na, Chen, Xiequn, Gao, Guangxun
Publicado 2018

New progress in the study of germline susceptibility genes of myeloid neoplasms

por Bi, Lei, Ma, Tianyuan, Li, Xu, Wei, Lai, Liu, Zinuo, Feng, Bingyue, Dong, Baoxia, Chen, Xiequn
Publicado 2021

Pharmacological inhibition of EZH2 combined with DNA-damaging agents interferes with the DNA damage response in MM cells

por Xu, Li, Tang, Hailong, Wang, Kai, Zheng, Yanhua, Feng, Juan, Dong, Hongjuan, Jin, Yulong, Cao, Chun, Chen, Xiequn, Gao, Guangxun
Publicado 2019

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway

por Jin, Yulong, Xu, Li, Wu, Xiaodong, Feng, Juan, Shu, Mimi, Gu, Hongtao, Gao, Guangxun, Zhang, Jinyi, Dong, Baoxia, Chen, Xiequn
Publicado 2019

Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study

por Mei, Heng, Chen, Xiequn, Zhou, Jianfeng, Luo, Jianmin, Shi, Qingzhi, Liu, Jing, Wu, Depei, Chen, Guoan, Tai, Yanfei, Xiong, Junye, Zou, Jianjun, Hu, Yu
Publicado 2022

Mammalian Diaphanous-Related Formin 1 Regulates GSK3β-Dependent Microtubule Dynamics Required for T Cell Migratory Polarization

por Dong, Baoxia, Zhang, Steven S., Gao, Wen, Su, Haichun, Chen, Jun, Jin, Fuzi, Bhargava, Ajay, Chen, Xiequn, Jorgensen, Lars, Alberts, Arthur S., Zhang, Jinyi, Siminovitch, Katherine A.
Publicado 2013

P869: UPDATED RESULTS OF A PHASE I, OPEN-LABEL STUDY OF BCMA/CD19 DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

por Du, Juan, Fu, Weijun, Jiang, Hua, Dong, Baoxia, Gao, LI, Liu, LI, Ge, Jian, He, Aili, LI, Lu, Lu, Jing, Chen, Xiequn, Liu, Jia, Zhang, Qi, He, Jiaping, Weng, Lihong, Zhang, Hua, Shen, Lianjun, Cao, Wei, LI, Wenling
Publicado 2023

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MA...

por Qiu, Lugui, Xia, Zhongjun, Fu, Chengcheng, Chen, Wenming, Chang, Chunkang, Fang, Baijun, An, Gang, Wei, Yongqiang, Cai, Zhen, Gao, Sujun, Weng, Jianyu, Chen, Lijuan, Jing, Hongmei, Li, Fei, Liu, Zhuogang, Chen, Xiequn, Liu, Jing, Wang, Aihua, Yu, Yang, Xiang, Wenxi, Lynch, Kevin, Yu, Zhinuan, Fu, Weijun
Publicado 2022

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation s...

por Hou, Jian, Jin, Jie, Xu, Yan, Wu, Depei, Ke, Xiaoyan, Zhou, Daobin, Lu, Jin, Du, Xin, Chen, Xiequn, Li, Junmin, Liu, Jing, Gupta, Neeraj, Hanley, Michael J., Li, Hongmei, Hua, Zhaowei, Wang, Bingxia, Zhang, Xiaoquan, Wang, Hui, van de Velde, Helgi, Richardson, Paul G., Moreau, Philippe
Publicado 2017

Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study

por Huang, Xiaojun, Qiu, Lugui, Jin, Jie, Zhou, Daobin, Chen, Xiequn, Hou, Ming, Hu, Jianda, Hu, Yu, Ke, Xiaoyan, Li, Junmin, Liang, Yingmin, Liu, Ting, Lv, Yue, Ren, Hanyun, Sun, Aining, Wang, Jianmin, Zhao, Chunting, Salman, Mariya, Sun, Steven, Howes, Angela, Wang, Jingzhao, Wu, Peng, Li, Jianyong
Publicado 2018

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placeb...

por Xia, Zhongjun, Leng, Yun, Fang, Baijun, Liang, Yang, Li, Wei, Fu, Chengcheng, Yang, Linhua, Ke, Xiaoyan, Jiang, Hua, Weng, Jianyu, Liu, Li, Zhao, Yaozhong, Zhang, Xuejun, Huang, Zhongxia, Liu, Aichun, Shi, Qingzhi, Gao, Yuhuan, Chen, Xiequn, Pan, Ling, Cai, Zhen, Wang, Zhao, Wang, Yafei, Fan, Yaqun, Hou, Ming, Ma, Yigai, Hu, Jianda, Liu, Jing, Zhou, Jianfeng, Zhang, Xiaohong, Meng, Haitao, Lu, Xuzhang, Li, Fei, Ren, Hanyun, Huang, Bintao, Shao, Zonghong, Zhou, Hebing, Hu, Yu, Yang, Shifang, Zheng, Xiangjun, Wei, Peng, Pang, Hongyan, Yu, Wei, Liu, Yuzhang, Gao, Sujun, Yan, Lingzhi, Ma, Yanping, Jing, Hongmei, Du, Juan, Ling, Wei, Zhang, Jingyi, Sui, Weiwei, Wang, Fuxu, Li, Xin, Chen, Wenming
Publicado 2023

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

por Shi, Yuankai, Jia, Bo, Xu, Wei, Li, Wenyu, Liu, Ting, Liu, Peng, Zhao, Weili, Zhang, Huilai, Sun, Xiuhua, Yang, Haiyan, Zhang, Xi, Jin, Jie, Jin, Zhengming, Li, Zhiming, Qiu, Lugui, Dong, Mei, Huang, Xiaobing, Luo, Yi, Wang, Xiaodong, Wang, Xin, Wu, Jianqiu, Xu, Jingyan, Yi, Pingyong, Zhou, Jianfeng, He, Hongming, Liu, Lin, Shen, Jianzhen, Tang, Xiaoqiong, Wang, Jinghua, Yang, Jianmin, Zeng, Qingshu, Zhang, Zhihui, Cai, Zhen, Chen, Xiequn, Ding, Kaiyang, Hou, Ming, Huang, Huiqiang, Li, Xiaoling, Liang, Rong, Liu, Qifa, Song, Yuqin, Su, Hang, Gao, Yuhuan, Liu, Lihong, Luo, Jianmin, Su, Liping, Sun, Zimin, Tan, Huo, Wang, Huaqing, Wang, Jingwen, Wang, Shuye, Zhang, Hongyu, Zhang, Xiaohong, Zhou, Daobin, Bai, Ou, Wu, Gang, Zhang, Liling, Zhang, Yizhuo
Publicado 2017

2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy

por Zhang, Xiaohui, Chen, Fangping, Chen, Xiequn, Cheng, Yunfeng, Fang, Meiyun, Feng, Jianming, Fu, Haixia, Gao, Hong, Han, Yue, He, Aili, Hou, Ming, Hu, Yu, Huang, Ruibin, Huang, Wenrong, Jing, Zhicheng, Kong, Peiyan, Liang, Aibin, Liang, Meiying, Liu, Daihong, Liu, Junling, Liu, Lin, Liu, Xiaowei, Ma, Liangming, Mei, Heng, Ni, Heyu, Niu, Ting, Peng, Jun, Qiao, Jianlin, Ren, Jinhai, Song, Yongping, Tang, Liang V., Tong, Tong, Wang, Shaoyuan, Wang, Xin, Wang, Zhao, Wei, Hui, Wu, Depei, Wu, Guangsheng, Xu, Caigang, Xu, Xue, Xu, Yajing, Yang, Linhua, Yang, Renchi, Yang, Tonghua, Yin, Chenghong, Yu, Li, Zhang, Guangsen, Zhang, Lei, Zhang, Liansheng, Zhang, Xi, Zhao, Weili, Zhao, Yongqiang, Zhou, Daobin, Zhou, Hu, Zhou, Zeping, Zhu, Tienan, Wang, Jianliu, Huang, Xiaojun
Publicado 2022